Denosumab - Wikipedia
Denosumab, sold under the brand names Prolia among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.
Denosumab (subcutaneous route) - Mayo Clinic
It is used to prevent bone problems in patients with multiple myeloma and bone metastases (cancer that has spread) from tumors. Denosumab is also used to treat giant cell tumor of the bone that cannot be removed by surgery.
Prolia: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年5月29日 · Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every 6 months by a healthcare provider to: Increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. Bone is always breaking down and reforming.
Prolia Injection (Denosumab): Uses & Side Effects - Cleveland Clinic
DENOSUMAB (den oh sue mab) slows bone breakdown. Prolia is used to treat osteoporosis in women after menopause and in men, and in people who are taking corticosteroids for 6 months or more.
Denosumab - StatPearls - NCBI Bookshelf
2024年2月28日 · Denosumab is a bone anti-resorptive drug used for the treatment of the following: FDA-Approved Indications. Prevention of skeletal-related events: Denosumab is indicated for bone pain and fractures secondary to multiple myeloma or bone metastases from solid tumors. Used in conjunction with treatments for primary malignancy. [1] .
Denosumab - Drugs.com
2024年1月21日 · What is denosumab? The Prolia brand of denosumab is used in adults to treat osteoporosis or bone loss in people who: are at high risk for broken bones; and. who cannot use another osteoporosis medicine or these medicines did not work well. Prolia is sometimes used in people whose bone fracture is caused by certain medicines or cancer treatments.
Prolia (denosumab) - Uses, Side Effects, and More - WebMD
2024年7月3日 · What is Prolia used for? Prolia (denosumab) is commonly used to treat osteoporosis, a condition in which the bones are thinner, weaker, and more prone to breakage. Prolia may be prescribed for...
Denosumab Injection: MedlinePlus Drug Information
When a denosumab injection product (Prolia, Jubbonti) is used to treat osteoporosis or bone loss, it is usually given once every 6 months. When a denosumab injection product (Wyost, Xgeva) is used to reduce the risk of fractures from multiple myeloma, or cancer that has spread to the bones, it is usually given once every 4 weeks.
Denosumab (Prolia, Xgeva) | Cancer information - Cancer …
Denosumab is a type of targeted drug called a monoclonal antibody. It is also known as Prolia and Xgeva. You pronounce denosumab as den-oh-sue-mab. It is a treatment for secondary bone cancer (cancer that has spread to the bones). It helps to strengthen the bones and prevent fractures for some types of cancer.
Denosumab - NCI - National Cancer Institute
giant cell tumor of the bone that cannot be removed by surgery. It is used in adults and in adolescents whose bones have finished growing. These uses are approved for the Xgeva brand of denosumab. Denosumab is approved to prevent: broken bones and other bone problems caused by multiple myeloma or by solid tumors that have spread to bone.
- 某些结果已被删除